
Cardiologist

No OPD information available
Heart Failure with Preserved Ejection Fraction (HFpEF)
Heart Failure
Atrial Fibrillation
Cardiac Ablation
Donna Vizi is a female healthcare provider who specializes in helping patients with heart-related issues like Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Atrial Fibrillation, and Cardiac Ablation.
Donna Vizi works with patients to improve their heart health using special skills and treatments. She carefully listens to patients, conducts thorough examinations, and creates personalized treatment plans to help them feel better.
Patients trust Donna Vizi because she communicates clearly and compassionately. She takes the time to explain medical information in a way that patients can understand, making them feel supported and cared for.
Donna Vizi stays updated with the latest medical knowledge and research by attending conferences, reading scientific journals, and collaborating with other experts in the field. This helps her provide the best possible care to her patients.
Donna Vizi works closely with colleagues and other medical professionals to ensure that patients receive comprehensive and coordinated care. By sharing knowledge and expertise, she and her colleagues can offer the most effective treatments to their patients.
Donna Vizi's work has made a positive impact on many patients' lives. Her dedication to improving heart health and her innovative approaches to treatment have helped numerous individuals lead healthier and happier lives.
One of Donna Vizi's notable publications is "Comparison of Continuous Milrinone Versus Dobutamine on Pulmonary Pressures in Patients With Advanced Heart Failure," published in the Journal of the American Heart Association. She has also conducted clinical trials, such as "Interactions Between The Serotonin Transporter And Sympathetic Nervous System Activation In Patients With Major Depressive Disorder," which have contributed valuable insights to the medical field.
Overall, Donna Vizi is a trusted healthcare provider who is committed to helping patients with heart-related conditions through her expertise, compassion, and dedication to staying informed about the latest advancements in medical research and treatment.
Enrollment Status: Completed
Published: September 14, 2023
Intervention Type: Drug
Study Drug: Selective Serotonin Re-Uptake Inhibitor (SSRI) Antidepressant
Study Phase: Phase 4
